Lidia Ruiz Tabuenca

Impact of CD4 T cell count on the outcome of planned treatment interruptions in early-treated human immunodeficiency virus-infected children.

Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.

Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with =250/microL CD4 T cells and undetectable plasma virus load.

New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses.